Cancer Treatment Modalities: An Interdisciplinary Approach
暫譯: 癌症治療方式：跨學科方法
Rezaei, Nima
- 出版商: Springer
- 出版日期: 2025-08-20
- 售價: $8,730
- 貴賓價: 9.5 折 $8,294
- 語言: 英文
- 頁數: 678
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 3032038650
- ISBN-13: 9783032038654
海外代購書籍(需單獨結帳)
相關主題
商品描述
The "Cancer Treatment Modalities: An Interdisciplinary Approach" is the twenty fourth volume of the "Interdisciplinary Cancer Research" series, publishes comprehensive volume on cancer treatment. The volume starts with a chapter on an interdisciplinary approach to biomarker discovery for cancer treatment, followed by other chapters on multidisciplinary approach in cancer management; and the interplay between inflammation and cancer progression. Cancer stem cells and mesenchymal stem cells are discussed in cancer therapy in other chapters. RNA epigenetics in cancer diagnosis and treatment as well as different aspects of telomerase inhibitors in cancer treatment are the subjected of subsequent chapters. Then bioimplants for the reconstructive surgery and the interplay of ferroptosis and cuproptosis in cancer are discussed. Liquid biopsy and cancer and mitochondrial transplantation are the subjects of other chapters. Microbial-based therapies in cancer treatment and bacteria-based approach to cancer therapy are the subjects of final chapters of this volume. This is the main concept of Cancer Immunology Project (CIP), which is a part of Universal Scientific Education and Research Network (USERN). This interdisciplinary book will be of special value for those who wish to have an update on cancer treatment.
商品描述(中文翻譯)
《癌症治療模式：跨學科方法》是《跨學科癌症研究》系列的第二十四卷，出版了有關癌症治療的綜合性著作。本卷以一章關於癌症治療的生物標記發現的跨學科方法開始，接著是關於癌症管理的多學科方法以及炎症與癌症進展之間相互作用的其他章節。癌症幹細胞和間充質幹細胞在癌症治療中的討論也出現在其他章節中。隨後的章節探討了RNA表觀遺傳學在癌症診斷和治療中的應用，以及端粒酶抑制劑在癌症治療中的不同方面。接著討論了重建手術中的生物植入物以及鐵死亡（ferroptosis）和銅死亡（cuproptosis）在癌症中的相互作用。液體活檢和癌症以及線粒體移植是其他章節的主題。本卷的最後幾章探討了微生物基礎的癌症治療和基於細菌的癌症治療方法。這是癌症免疫學計畫（Cancer Immunology Project, CIP）的主要概念，該計畫是全球科學教育與研究網絡（Universal Scientific Education and Research Network, USERN）的一部分。這本跨學科的書籍對於希望了解癌症治療最新進展的人士將具有特別的價值。
作者簡介
Professor Nima Rezaei gained his medical degree (MD) from Tehran University of Medical Sciences and subsequently obtained an MSc in Molecular and Genetic Medicine and a PhD in Clinical Immunology and Human Genetics from the University of Sheffield, UK. He also spent a short-term fellowship of Pediatric Clinical Immunology and Bone Marrow Transplantation in the Newcastle General Hospital. Professor Rezaei is now the Full Professor of Immunology and Vice Dean of Research and Technologies, School of Medicine, Tehran University of Medical Sciences, and the co-founder and Head of the Research Center for Immunodeficiencies. He is also the Founder of Universal Scientific Education and Research Network (USERN). Prof. Rezaei has already been the Director of more than two hundred research projects and has designed and participated in several international collaborative projects. Prof. Rezaei is the editor, editorial assistant, or editorial board member of more than fifty international journals. He has edited more than one hundred international books, has presented more than a thousand lectures/posters in congresses/meetings, and has published more than 1,700 scientific papers in the international journals.
作者簡介(中文翻譯)
教授尼瑪·雷扎伊（Nima Rezaei）於德黑蘭醫科大學獲得醫學學位（MD），隨後在英國謝菲爾德大學獲得分子與遺傳醫學碩士學位（MSc）及臨床免疫學與人類遺傳學博士學位（PhD）。他還在紐卡斯爾綜合醫院完成了兒科臨床免疫學和骨髓移植的短期研究獎學金。雷扎伊教授目前是德黑蘭醫科大學免疫學的全職教授及研究與技術副院長，並且是免疫缺陷研究中心的共同創辦人及負責人。他也是全球科學教育與研究網絡（USERN）的創始人。雷扎伊教授已經擔任超過兩百個研究項目的主任，並設計及參與了幾個國際合作項目。雷扎伊教授是超過五十本國際期刊的編輯、編輯助理或編輯委員會成員。他編輯了超過一百本國際書籍，並在會議/研討會上發表了超過一千場演講/海報，已在國際期刊上發表了超過1,700篇科學論文。
